Total Payments
$6,712
2024 Payments
$1,645
Companies
52
Transactions
252
Payment Breakdown by Category
Food & Beverage$6,583 (98.1%)
Education$129.38 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,583 | 250 | 98.1% |
| Education | $129.38 | 2 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $607.86 | 40 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $510.87 | 24 | $0 (2024) |
| Daiichi Sankyo Inc. | $414.36 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $410.18 | 10 | $0 (2024) |
| GENZYME CORPORATION | $372.93 | 6 | $0 (2024) |
| Genentech USA, Inc. | $363.79 | 23 | $0 (2024) |
| BeiGene USA, Inc. | $361.22 | 3 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $312.50 | 1 | $0 (2024) |
| Amgen Inc. | $307.30 | 24 | $0 (2018) |
| Celgene Corporation | $218.95 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,645 | 43 | Myriad Genetic Laboratories, Inc. ($312.50) |
| 2023 | $711.64 | 6 | Jazz Pharmaceuticals Inc. ($150.00) |
| 2022 | $918.16 | 9 | E.R. Squibb & Sons, L.L.C. ($195.29) |
| 2021 | $631.24 | 6 | Daiichi Sankyo Inc. ($248.68) |
| 2019 | $96.00 | 1 | Genentech USA, Inc. ($96.00) |
| 2018 | $1,266 | 93 | Novartis Pharmaceuticals Corporation ($195.21) |
| 2017 | $1,444 | 94 | Novartis Pharmaceuticals Corporation ($237.63) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | SERVIER PHARMACEUTICALS LLC | — | Food and Beverage | In-kind items and services | $24.30 | General |
| 12/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $82.92 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Oncology | ||||||
| 10/31/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $96.33 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $312.50 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $87.45 | General |
| Category: Hematology | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Genentech USA, Inc. | Columvi (Biological), Gazyva, Lunsumio | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: BioOncology | ||||||
| 08/15/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $17.10 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $93.76 | General |
| Category: Oncology | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: BioOncology | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.09 | General |
| 06/11/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $97.73 | General |
| 06/04/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Oncology | ||||||
| 05/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: ONCOLOGY | ||||||
About Dr. George Kovach, MD
Dr. George Kovach, MD is a Hematology & Oncology healthcare provider based in Davenport, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982663985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Kovach, MD has received a total of $6,712 in payments from pharmaceutical and medical device companies, with $1,645 received in 2024. These payments were reported across 252 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($6,583).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Davenport, IA
- Active Since 03/20/2006
- Last Updated 12/12/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982663985
Products in Payments
- BRUKINSA (Drug) $361.22
- MYRISK (Device) $312.50
- SARCLISA (Biological) $302.43
- OPDIVO (Biological) $217.83
- Neulasta (Biological) $204.73
- REBLOZYL (Biological) $185.30
- CALQUENCE (Drug) $179.23
- INJECTAFER (Drug) $161.73
- Enhertu (Drug) $154.90
- KEYTRUDA (Biological) $153.37
- ZEPZELCA (Drug) $150.00
- Imbruvica (Drug) $148.40
- AFINITOR (Drug) $148.12
- DARZALEX (Biological) $141.36
- Revlimid (Drug) $131.50
- KRAZATI (Drug) $131.15
- TAGRISSO (Drug) $128.53
- SCEMBLIX (Drug) $124.99
- COSELA (Drug) $117.45
- DOPTELET (Drug) $112.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.